Literature DB >> 1537300

Adaptation of islets of Langerhans to pregnancy: increased islet cell proliferation and insulin secretion correlates with the onset of placental lactogen secretion.

J A Parsons1, T C Brelje, R L Sorenson.   

Abstract

To elucidate the temporal profile of adaptive changes of the islets of Langerhans to the increased insulin demands of pregnancy, we have studied islet cell proliferation and insulin secretion during gestation in the rat. 5-Bromo-2'-deoxyuridine incorporation into dividing islet cells was significantly (P less than 0.05) increased over age-matched controls by day 10, rose continuously to a peak at day 14, and then returned to control levels by day 18. By day 20, cell division was significantly inhibited (P less than 0.05). The pattern of changes in insulin secretory profiles observed with perfused pancreata of pregnant animals was similar to that obtained for islet cell proliferation. Both the threshold of glucose-stimulated insulin secretion and the amount of above threshold insulin secretion began to diverge from controls by day 10. By day 12, the glucose-stimulation threshold was significantly decreased from 5.7 mM glucose to 3.3 mM (P less than 0.05), remained at this low level through day 15, and returned toward normal by day 20. Concomitant with the increased sensitivity of B cells to glucose, the above threshold insulin secretion was significantly increased by day 12 (P less than 0.05), peaked at day 15, and returned to control levels by day 20. This insulin secretory data demonstrates that the increased sensitivity of B cells to glucose is an important component of the adaptation of islets during pregnancy to the increased demand for insulin at physiological concentrations of plasma glucose. To correlate the above changes in islet cell proliferation and insulin secretion with levels of placental lactogen (PL), serum lactogenic hormone activity was measured by Nb2 lymphoma cell replication assays. This analysis revealed the expected biphasic pattern: a midpregnancy peak at day 12, followed by a nadir at day 14, and then continuously elevated levels until term. The bioassay data agreed with the known secretory profiles of rat (r) PL-I (midpregnancy) and rPL-II (late pregnancy). Our results provide the first systematic evaluation of changes in islet function during pregnancy in the rat. In addition, they provide evidence that rPL-I may be the critical hormonal signal which triggers the primary adaptive changes in islet function characteristic of pregnancy. The return to normal values of insulin secretion and inhibition of cell division observed at day 20 in the presence of high concentrations of rPL-II suggests that other inhibitory influences become dominant in the later stages of rat pregnancy.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1537300     DOI: 10.1210/endo.130.3.1537300

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  160 in total

Review 1.  Pancreatic stem cells: from possible to probable.

Authors:  Fang-Xu Jiang; Grant Morahan
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

2.  Nutritional programming of pancreatic β-cell plasticity.

Authors:  David J Hill
Journal:  World J Diabetes       Date:  2011-08-15

3.  Beta cell adaptation in pregnancy: a major difference between humans and rodents?

Authors:  M Genevay; H Pontes; P Meda
Journal:  Diabetologia       Date:  2010-07-10       Impact factor: 10.122

4.  Loss of Foxd3 results in decreased β-cell proliferation and glucose intolerance during pregnancy.

Authors:  Jennifer L Plank; Audrey Y Frist; Alison W LeGrone; Mark A Magnuson; Patricia A Labosky
Journal:  Endocrinology       Date:  2011-09-27       Impact factor: 4.736

5.  Research Resource: A Dual Proteomic Approach Identifies Regulated Islet Proteins During β-Cell Mass Expansion In Vivo.

Authors:  Signe Horn; Jeannette S Kirkegaard; Soraya Hoelper; Philip A Seymour; Claude Rescan; Jens H Nielsen; Ole D Madsen; Jan N Jensen; Marcus Krüger; Mads Grønborg; Jonas Ahnfelt-Rønne
Journal:  Mol Endocrinol       Date:  2015-12-09

Review 6.  Development, growth and maintenance of β-cell mass: models are also part of the story.

Authors:  Anmar Khadra; Santiago Schnell
Journal:  Mol Aspects Med       Date:  2015-02-23

7.  Proliferation of sorted human and rat beta cells.

Authors:  G Parnaud; D Bosco; T Berney; F Pattou; J Kerr-Conte; M Y Donath; C Bruun; T Mandrup-Poulsen; N Billestrup; P A Halban
Journal:  Diabetologia       Date:  2007-11-10       Impact factor: 10.122

Review 8.  Targeting the pancreatic β-cell to treat diabetes.

Authors:  Amedeo Vetere; Amit Choudhary; Sean M Burns; Bridget K Wagner
Journal:  Nat Rev Drug Discov       Date:  2014-02-14       Impact factor: 84.694

9.  Serotonin regulates glucose-stimulated insulin secretion from pancreatic β cells during pregnancy.

Authors:  Mica Ohara-Imaizumi; Hail Kim; Masashi Yoshida; Tomonori Fujiwara; Kyota Aoyagi; Yukiko Toyofuku; Yoko Nakamichi; Chiyono Nishiwaki; Tadashi Okamura; Toyoyoshi Uchida; Yoshio Fujitani; Kimio Akagawa; Masafumi Kakei; Hirotaka Watada; Michael S German; Shinya Nagamatsu
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

Review 10.  Advances in β cell replacement and regeneration strategies for treating diabetes.

Authors:  Jacqueline R Benthuysen; Andrea C Carrano; Maike Sander
Journal:  J Clin Invest       Date:  2016-10-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.